✦ LIBER ✦

p53 Mutations in non-small-cell lung cancers occurring in individuals without a past history of active smoking

✍ Scribed by Takagi, Y; Osada, H; Kuroishi, T; Mitsudomi, T; Kondo, M; Niimi, T; Saji, S; Gazdar, AF; Takahashi, T; Minna, JD

Book ID: 109837518
Publisher: Nature Publishing Group
Year: 1998
Tongue: English
Weight: 839 KB
Volume: 77
Category: Article
ISSN: 0007-0920
DOI: 10.1038/bjc.1998.258

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Survival in operable non-small-cell lung

Survival in operable non-small-cell lung cancer: Role of p53 mutations, tobacco smoking and asbestos exposure

✍ Thanos Sioris; Kirsti Husgafvel-Pursiainen; Antti Karjalainen; Sisko Anttila; An 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 68 KB 👁 2 views

Validated markers are needed to identify operable lung cancer patients with poor prognosis. About one-half of nonsmall-cell lung cancers (NSCLCs) carry a mutation in the p53 tumor-suppressor gene. We examined 101 NSCLC patients for surgical stage, completeness of resection, tobacco smoking, asbestos

Analysis of p53 mutations in histologica

Analysis of p53 mutations in histologically normal lung tissues and lung tumors from non-small cell lung cancer patients

✍ Weimin Gao; Hussam H. Mady; Mona F. Melhem; Phouthone Keohavong 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB

## Abstract Our previous study showed a characteristic p53 mutational spectrum in lung tumors from lung cancer patients in the Western Pennsylvania region. To further understand the involvement of p53 mutations in lung tumor development, in this study we compared p53 mutational spectra and distribu

Association of smoking with apoptosis-re

Association of smoking with apoptosis-regulated proteins (Bcl-2, Bax and p53) in resected non-small-cell lung cancers

✍ Takaomi Hanaoka; Jun Nakayama; Jun Mukai; Shinji Irie; Takeshi Yamanda; Taka-Aki 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 42 KB 👁 2 views

FIGURE 1 -Survival after surgery of patients with NSCLC according to p53 expression level. Log-rank tests used for comparisons.

Mutational analysis of p51A/TAp63γ, a p5

Mutational analysis of p51A/TAp63γ, a p53 homolog, in non-small cell lung cancer and breast cancer

✍ Sunahara, Masao; Shishikura, Tomotane; Takahashi, Masato; Todo, Satoru; Yamamoto 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 290 KB

Mutations in exon 7 and 8 of p53 as poor

Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer

✍ Huang, Cheng-long; Taki, Toshihiko; Adachi, Masashi; Konishi, Takaaki; Higashiya 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 357 KB

Intragenic mutations of the p16INK4, p15

Intragenic mutations of the p16INK4, p15INK4B and p18 genes in primary non-small-cell lung cancers

✍ Marek R. Rusin; Aikou Okamoto; Mieczyslaw Chorazy; Kazimierz Czyzewski; Jolanta 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 721 KB

The p p ! 6INK4 and p I8 genes are members of the gene famil coding for inhibitors of cyclin-dependent kinases 4 and 6. frequently deleted in many human neoplasms. To examine the role of these 3 genes in lung carcinogenesis, somatic mutations within the genes were analyzed by single-strand conformat